Terug
66
35
Ook genoteerd als
SAEYY
OTC
Dagbereik
€ 45,18
€ 62,99
52-Weeksbereik
€ 45,18
€ 148,22
Volume
400
50D / 200D Gem.
€ 66,04
/
€ 102,10
Vorige Slotkoers
€ 45,18
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -24,4 | 0,4 |
| P/B | 2,0 | 2,9 |
| ROE % | -8,0 | 3,8 |
| Net Margin % | -1,3 | 3,9 |
| Rev Growth 5Y % | 29,0 | 10,0 |
| D/E | 0,9 | 0,2 |
Belangrijkste Punten
Revenue grew 29,04% annually over 5 years — strong growth
Negative free cash flow of -56,28M
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,03%
Capital efficient — spends only 2,70% of revenue on capex
Groei
Revenue Growth (5Y)
29,04%
Revenue (1Y)24,01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-7,99%
ROIC-2,04%
Net Margin-1,28%
Op. Margin-0,81%
Veiligheid
Debt / Equity
0,91
Current Ratio1,55
Interest Coverage-1,17
Waardering
P/E Ratio
-24,39
P/B Ratio2,00
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 24,01% | Revenue Growth (3Y) | 27,84% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 29,04% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,94B | Net Income (TTM) | -37,69M |
| ROE | -7,99% | ROA | -3,02% |
| Gross Margin | 20,19% | Operating Margin | -0,81% |
| Net Margin | -1,28% | Free Cash Flow (TTM) | -56,28M |
| ROIC | -2,04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,91 | Current Ratio | 1,55 |
| Interest Coverage | -1,17 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -24,39 | P/B Ratio | 2,00 |
| P/S Ratio | 0,31 | PEG Ratio | 1,97 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 919,02M | Enterprise Value | 1,24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,94B | 2,37B | 1,80B | 1,20B | 1,06B |
| Net Income | -37,69M | -45,46M | -12,04M | -77,65M | -74,19M |
| EPS (Diluted) | -1,87 | -2,26 | -0,63 | -4,32 | -4,15 |
| Gross Profit | 593,48M | 545,78M | 440,38M | 331,79M | 266,53M |
| Operating Income | -23,79M | -38,99M | -17,30M | -69,17M | -65,70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,25B | 1,00B | 1,02B | 729,47M | 783,08M |
| Total Liabilities | 767,01M | 493,32M | 469,56M | 374,84M | 367,66M |
| Shareholders' Equity | 459,03M | 483,98M | 522,19M | 354,63M | 415,41M |
| Total Debt | 415,44M | 247,38M | 244,84M | 255,19M | 236,43M |
| Cash & Equivalents | 92,37M | 96,61M | 83,78M | 66,44M | 247,08M |
| Current Assets | 619,17M | 500,02M | 499,52M | 343,92M | 432,76M |
| Current Liabilities | 399,85M | 249,73M | 223,72M | 119,31M | 124,09M |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#105 of 616
Custom
Full Throttle
#96 of 146
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Full Throttle
Mar 24, 2026